U.S. Markets closed

Syneron Medical Ltd. (ELOS)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.90+0.05 (+0.46%)
At close: 4:00PM EDT

10.90 0.00 (0.00%)
After hours: 4:25PM EDT

People also watch
CUTRCYNOANGOSPNCWMGI

Syneron Medical Ltd.

Tavor Building
Industrial Zone
Yokneam Illit 20692
Israel
972 73 24 42200
http://www.syneron-candela.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees817

Key Executives

NameTitlePayExercisedAge
Dr. Shimon Eckhouse Ph.D.Co-Founder and Chairman446kN/A72
Mr. Amit MeridorChief Exec. Officer and Pres699kN/A56
Mr. Hugo GoldmanChief Financial Officer465kN/A63
Mr. Robert FielitzManaging Director of Europe, Middle East & Africa and Exec. VP471kN/A49
Mr. Robert L. RuckExec. VP of Asia Pacific542kN/A56
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Syneron Medical Ltd., together with its subsidiaries, researches, develops, manufactures, markets, and sells aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. It offers products, which are used for various non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and tattoo removal. The company also provides cosmetic and aesthetic lasers, and light-based systems used by physicians and personal care practitioners; non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products through a system-specific skin patch. It sells its products to dermatologists, plastic surgeons, other cosmetic physicians, qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and directly to end-users. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.

Corporate Governance

Syneron Medical Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.